Preclinical in vivo CRO for advanced models of pathologies and imaging
Imavita is a preclinical CRO specializing in in vivo models that approximate or replicate human pathologies. Our models enable precise evaluations of drug efficacy, safety, and pharmacokinetics. Utilizing both healthy and pathological models in rodents and non-rodents, we provide customized solutions to study therapeutic mechanisms, validate drug targets, and optimize dosing strategies. Imavita integrates advanced imaging technologies with its in vivo expertise to support drug development pipelines.
Advantages of collaborating with Imavita
Simulate human pathologies with precision
Imavita’s in vivo models approximate human diseases, providing insights into drug mechanisms and therapeutic potential. Our flexible and innovative approach ensures that we can offer niche, specialized models that larger organizations can not provide in due times.
Accelerate preclinical research with a complete panel of evaluation
With our specific and complete expertise and technologies, as a preclinical CRO we offer you a panel of studies for drug evaluation.
- Efficacy : Assess the therapeutic potential of new compounds.
- Pharmacokinetics (PK) : Analyze absorption, distribution, metabolism, and elimination.
- Drugs tolerance / Safety : Identify potential adverse effects to optimize dosing strategies (non GLP).
Imavita’s expertise as a preclinical in vivo CRO
Different animal species
Our preclinical in vivo CRO services use a variety of laboratories species.
Rodents: Rat, mouse, hamster, guinea pig
Non-rodents: Rabbit
Integration of imaging with in vivo models
- Precise analysis of imaging biomarkers from ex vivo models using advanced techniques.
- As a CRO specializing in preclinical models and imaging, Imavita integrates cutting-edge techniques into in vivo studies to deliver advanced non-invasive insights: Live animal behaviour video recording.
- Fluorescence Reflectance and Imaging (FRI), Fluorescence Tomography (FMT) and Bioluminescence: Dynamic monitoring of disease progression.
- Ultrasonography ((low frequency) and Optical Coherence Tomography (OCT): High-resolution analysis of structural and functional changes.
- PET/CT, and MRI (7T, in partnership): Track real-time drug biodistribution and therapeutic effects.
Diversity of in vivo pathological models
Our models are tailored to study several human conditions.
Dermatology
Psoriasis, atopic dermatitis, acne, rosacea, and wound healing.
Oncology
Bone healing, osteoporosis, and arthritis models.
Osteo-articular
Tumor growth, metastatic models, biological target confirmation.
Neurology
Neuro-inflammation and neuropathies.
Imavita advantages for your in vivo preclinical studies
Tailored solutions for precision research
A team of seasoned scientific experts ready to listen to your specific needs.
Custom-designed models adapted to your therapeutic goals.
Long experience expertise in replicating complex human disease mechanisms.
Custom-designed models adapted to your therapeutic goals.
Long experience expertise in replicating complex human disease mechanisms.
Ethical and sustainable practices
Application of the 3Rs rules (Replacement, Reduction, Refinement).
Reduced animal usage through longitudinal studies and non-invasive imaging.
Reduced animal usage through longitudinal studies and non-invasive imaging.
Cutting-edge technology
Advanced imaging tools for high-resolution, real-time analysis.
Quantitative image analysis for reliable and reproducible results.
Quantitative image analysis for reliable and reproducible results.
Discover our complete preclinical services for comprehensive partnership.
In vitro models
Ex vivo models
Preclinical imaging
Image analysis
FAQ
What is a preclinical in vivo CRO?
A preclinical in vivo CRO specializes in providing animal models and in vivo studies to support drug discovery and development. It offers services such as efficacy studies, pharmacokinetics (PK), and toxicology evaluations under physiological conditions.
How to integrate imaging into in vivo studies?
Advance your drug development with Imavita, a trusted preclinical in vivo CRO.